Skip to main content

Poster 22: A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care

Sofia Taverner1, David M Williams2, Cindy Eng1, Rebecca Watson1, Siba George2, Amanda Edwards2, Jeffrey W Stephens2,3

1Department of Acute Medicine, Morriston Hospital, Swansea Bay University Health Board, Swansea, UK;

2Department of Diabetes & Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, UK;

3Diabetes Research Group, Swansea Unive
 

Poster 16: The characteristics of lean diabetes in a multi-ethnic urban population

Gupta Prakhar; Ladwa Meera
Newham University Hospital, Barts Health NHS Trust
 

Background: Increasing rates of type 2 diabetes in the young have traditionally been associated with overweight and obesity. However, young-onset type 2 diabetes with low-to-normal BMI has been less well studied. We aimed to compare characteristics of lean and non-lean youth with type 2 diabetes.

Poster 15: Revisiting the “Type of Diabetes” in genetically susceptible patients

Chohan, Muhammad Tahir; Abouzaid, Mona; Aggarwal, Naveen
University Hospital North Tees
 

Introduction: Maturity Onset Diabetes of Young (MODY), an autosomal condition accounting for 1-2% of all diabetes usually presents in second to fourth decade. There are various subtypes of MODY with HNF1 alpha (MODY 3) being the most common of all (30-70%).

Poster 13: Tirzepatide as a novel therapeutic option for patients with type 2 diabetes: a pooled analysis of SURPASS 1-5 trials

Abdalla M.A ; Soyiri I.S; Atkin S L.A; Sathyapalan S.T.
Hull York Medical School, University of Hull. Hull, UK.
 Allam Diabetes centre, Hull University Teaching Hospital, NHS Trust. Hull, UK.
 School of postgraduate studies and research, RCIS Bahrain, Medical University of Bahrain, Kingdom of Bahrain.